Class I/II hybrid inhibitory oligodeoxynucleotide exerts Th1 and Th2 double immunosuppression

FEBS Open Bio

Volumn 3, Issue , 2013, Pages 41-45

  Ito, Yusuke ^a   Shigemori, Suguru ^a   Sato, Takashi ^b   Shimazu, Tomoyuki ^c   Hatano, Konomi ^a   Otani, Hajime ^a   Kitazawa, Haruki ^c   Shimosato, Takeshi ^a  

^a SHINSHU UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Class I iODN; Class I II hybrid iODN; Class II iODN; Immunosuppression; IODN

Indexed keywords

GAMMA INTERFERON; INHIBITORY OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; ISG3; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TH2 CELL;

MUS;

EID: 84871663497     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2012.11.002     Document Type: Article

References (21)

1. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
2. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
3. Yamada H., Gursel I., Takeshita F., Conover J., Ishii K.J., Gursel M., Takeshita S., Klinman D.M. Effect of suppressive DNA on CpG-induced immune activation. J. Immunol. 2002, 169:5590-5594.
4. Trieu A., Roberts T.L., Dunn J.A., Sweet M.J., Stacey K.J. DNA motifs suppressing TLR9 responses. Crit. Rev. Immunol 2006, 26:527-544.
5. Zeuner R.A., Ishii K.J., Lizak M.J., Gursel I., Yamada H., Klinman D.M., Verthelyi D. Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis Rheum 2002, 46:2219-2224.
6. Gursel I., Gursel M., Yamada H., Ishii K.J., Takeshita F., Klinman D.M. Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J. Immunol 2003, 171:1393-1400.
7. Klaschik S., Gursel I., Klinman D.M. CpG-mediated changes in gene expression in murine spleen cells identified by microarray analysis. Mol. Immunol 2007, 44:1095-1104.
8. Sato T., Yamamoto M., Shimosato T., Klinman D.M. Accelerated wound healing mediated by activation of Toll-like receptor 9. Wound Repair Regen 2010, 18:586-593.
9. Sato T., Shimosato T., Alvord W.G., Klinman D.M. Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation. J. Immunol 2008, 180:7648-7654.
10. Shimosato T., Fujimoto M., Tohno M., Sato T., Tateo M., Otani H., Kitazawa H. CpG oligodeoxynucleotides induce strong up-regulation of interleukin 33 via Toll-like receptor 9. Biochem. Biophys. Res. Commun 2010, 394:81-86.
11. Shimosato T., Tohno M., Sato T., Nishimura J., Kawai Y., Saito T., Kitazawa H. Identification of a potent immunostimulatory oligodeoxynucleotide from Streptococcus thermophilus lacZ. Anim. Sci. J. 2009, 80:597-604.
12. Shigemori S., Yonekura S., Sato T., Nakanishi M., Otani H., Shimosato T. Expression of a biologically active GFP-αS1-casein fusion protein in Lactococcus lactis. Curr. Microbiol. 2012, 64:569-575.
13. Hamada M., Kiryu H., Sato K., Mituyama T., Asai K. Prediction of RNA secondary structure using generalized centroid estimators. Bioinformatics 2009, 25:465-473.
14. Sato K., Hamada M., Asai K., Mituyama T. CENTROIDFOLD: a web server for RNA secondary structure prediction. Nucleic Acids Res. 2009, 37:W277-W280.
15. Klinman D.M., Tross D., Klaschik S., Shirota H., Sato T. Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides. Ann. NY Acad. Sci. 2009, 1175:80-88.
16. Dong L., Ito S., Ishii K.J., Klinman D.M. Suppressive oligonucleotides protect against collagen-induced arthritis in mice. Arthritis Rheum 2004, 50:1686-1689.
17. Wang Y.Z., Liang Q.H., Ramkalawan H., Zhang W., Zhou W.B., Xiao B., Tian F.F., Yang H., Li J., Zhang Y., Xu N.A. Inactivation of TLR9 by a suppressive oligodeoxynucleotides can ameliorate the clinical signs of EAN. Immunol Invest 2012, 41:171-182.
18. Ikeuchi H., Kinjo T., Klinman D.M. Effect of suppressive oligodeoxynucleotides on the development of inflammation-induced papillomas. Cancer Prev. Res. (Phila.) 2011, 4:752-757.
19. Fujimoto C., Klinman D.M., Shi G., Yin H., Vistica B.P., Lovaas J.D., Wawrousek E.F., Igarashi T., Chan C.C., Gery I. A suppressive oligodeoxynucleotide inhibits ocular inflammation. Clin. Exp. Immunol 2009, 156:528-534.
20. Shirota H., Gursel I., Gursel M., Klinman D.M. Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock. J. Immunol. 2005, 174:4579-4583.
21. Shirota H., Gursel M., Klinman D.M. Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma- and IL-12-mediated signaling. J. Immunol. 2004, 173:5002-5007.